Vaccines Archive — Page 8 of 14

March 4, 2021

Chikungunya antibody identified at VUMC moves forward

Evotec, a drug company headquartered in Hamburg, Germany, has begun a phase 1 clinical trial of a monoclonal antibody against the chikungunya virus that was identified at Vanderbilt University Medical Center.

By Bill Snyder
The study team includes (seated, from left) Adrienne Baughman, CCRP; Bob McClellan; Wesley Self, MD, MPH; Christina Kampe, CCRP; (standing, from left) Rendie McHenry; Bo Stubblefield, MD; Jon Casey, MD, MSCI; Todd Rice, MD, MSc; Natasha Halasa, MD, MPH; Jakea Johnson, MPH; Jim Chappell, MD, PhD; Carlos Grijalva, MD, MPH; and Kelsey Womack, PhD. Not pictured are Julia Rhoads, PhD; Chris Lindsell, PhD; Keipp Talbot; MD, MPH; and Kimberly Hart, MA. (photo by Donn Jones)
March 2, 2021

Study to evaluate effectiveness of COVID-19 vaccines in preventing hospitalization

As the Federal Drug Administration (FDA) considers adding a third COVID-19 vaccine to the rollout, a multicenter study led by Vanderbilt University Medical Center will evaluate how effective the vaccines are in preventing hospitalization from COVID-19.

By Kristin Smart
Jeff Balser, MD, PhD, talks about the many challenges VUMC has faced during the past year at this week’s Leadership assembly. (photo by Donn Jones)
February 18, 2021

Take care of you: 5 Takeaways from Leadership Assembly

In the 351 days since the COVID-19 Command Center opened to steer Vanderbilt University Medical Center through the pandemic, the workforce stepped up and contributed, keeping the health system on track to deliver care even as the landscape quaked with new challenges.

By Holly Fletcher
Ken and Kathy Hazelwood are among those who have received treatment at VUMC’s COVID Infusion Clinic.
February 10, 2021

More than 1,000 receive antibody infusions for COVID-19 at VUMC

As of Feb. 1,065 outpatients have received antibody infusions since the clinic opened on Nov. 18. Clinic officials estimated that the infusions have prevented about 70 patients from developing severe COVID-19 illness requiring hospitalization or emergency department evaluation.

By Bill Snyder
January 14, 2021

Vanderbilt Health Employer Solutions pivots during first year

In early 2020, several groups at Vanderbilt University Medical Center were busy planning an in-person event to announce the creation of Vanderbilt Health Employer Solutions, a team designed to provide workforce health and wellness services to businesses of all types and sizes. By March, it was clear that area employers needed a trusted source of information and support to manage the COVID-19 pandemic.

By Jamie Roberts
December 21, 2020

HERO-TOGETHER study seeks health care workers who receive COVID-19 vaccine

Health care workers, who have been disproportionately affected by the COVID-19 pandemic, will be the first tier of Vanderbilt University Medical Center employees to receive vaccine to prevent SARS-CoV-2 infection.

By Kathy Whitney